Dyax Corp. buy klostergang
Start price
18.06.15
/
50%
€21.87
Target price
27.01.16
€28.00
Performance (%)
63.96%
End price
27.01.16
€35.86
Summary
This prediction ended on 27.01.16 with a price of €35.86. With a performance of 63.96% the BUY prediction by klostergang was a big success. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Dyax Corp. | - | - | - | - |
| iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
| iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
| iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
| iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by klostergang for this prediction
In the thread Dyax Corp. diskutieren
Could be a juicy acquisition :
Dyax Corp is abiopharmaceutical company focused onHereditary Angioedema and Other Plasma-Kallikrein-Mediated (PKM)Disorders andLicensing and Funded Research Portfolio.
(Vom Mitglied beendet)